close

Enter

Log in using OpenID

Myeloproliferative Neoplasms Treatment Market By Drug, Growth, Trends, And Analysis, 2018-2026

embed
Rising awareness of molecular abnormalities and cellular pathways involved in the pathogenesis of MPNs is expected to facilitate the development of novel drugs, propels the Myeloproliferative Neoplasms treatment market growth in the near future
Myeloproliferative Neoplasms Treatment
Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,
AND OPPORTUNITY ANALYSIS, 2018-2026
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Myeloproliferative Neoplasms Treatment Market – Overview
Myeloproliferative Neoplasms (MPNs) are a group of rare disease, in which the bone marrow produces excess
blood cells. It can be white blood cells, red blood cells or platelets. The overproduction of blood cells by the bone
marrow creates hindrance in the smooth flow of blood, which leads to various symptoms such as progressive
cytopenias, cachexia and weight loss, splenomegaly, and blastic transformation. These conditions are developed
gradually over a period of time. Most people are diagnosed after the age of 60 years, when they were accompanied
by many other health issues, makes the treatment more difficult. The major symptoms associated with MPNs
include bleeding problem, anemia, chest pain, fatigue, enlarged spleen, and weight loss. According to Annals of
Hematology, approximately 90% of patients has experienced MPN-symptoms in past 12 months, wherein women
are reported to have higher overall burden than men. The treatment for myeloproliferative neoplasms is mainly
aimed to reduce the excess number of blood cells circulation. The concept of myleoproliferative disease was first
given by hematologist Williom Dameshek in 1950. However, in 2008, World Health Organization (WHO)
classified hematologic malignancies and renamed myloproliferative diseases to myeloproliferative neoplasms.
Rising awareness of molecular abnormalities and cellular pathways involved in the pathogenesis of MPNs is
expected to facilitate the development of novel drugs, propels the Myeloproliferative Neoplasms treatment market
growth in the near future
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Myeloproliferative Neoplasms Treatment Market Taxonomy:
Myeloproliferative neoplasm can significantly affect the quality of life of the patient. The
complication and treatments as well as the physiological strains of cancer diagnosis can affect
the physical and emotional wellbeing of patients. Effects of complication vary from depression,
fatigue, pain or depression with suicidal ideation. Moreover, patients can experience few or no
symptoms for a longer period of time. MPNs can be cured with proper monitoring and
treatment. There has been a major revolution in the management of MPNs by introduction of
JAK1 and JAK2 inhibitor and ruxolitinib. Ruxolitinib inhibits these two enzymes in order to
manage MPNs. The drug has also been proven as an alternative therapy for the treatment of
polycythemia vera. Further, the therapeutic armamentarium for MPN is still inadequate for
normalization of life span, reduction in cardiovascular complications, and prevention of
hematological progression.
Request for sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/930
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Myeloproliferative Neoplasms Treatment Market: Key Players
●
●
Collaboration among the biotech and pharmaceutical companies to identify new drugs for
MPNs is expected to accelerate the market growth
Novartis AG and Incyte Corporation are among the key players in Myeloproliferative
Neoplasms treatment market. According to MPN research foundation, biotech and
pharmaceutical companies are expected to propel the demand for improved treatments
and quickly connecting patients with latest treatment options. It is expected to lead
developing relationships with biotech and pharmaceuticals companies to identify new
areas for scientific exploration. For instance, Incyte Corporationis is developing inhibitor
for Janus Kinase (JAK) and also focusing on the discovery, development, and
commercialization of proprietary therapeutics globally.
View this report @ http://bit.ly/2v9K8l3
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization
focused on assisting its plethora of clients achieve transformational growth by helping
them make critical business decisions. We are headquartered in India, with an office at
the global financial capital in the U.S. Our client base includes players from across all
business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various
recommendations about operational improvements, technologies, emerging market
trends and new working methods. We offer both customized and syndicated market
research reports that help our clients create visionary growth plans to provide traction to
their business. We meticulously study emerging trends across various industries at both
the global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
SECTOR COVERAGE
Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARC
H
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our
clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained
growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
To know more about us, visit our website:
www.coherentmarketinsights.com
THANK YOU
© Coherent market Insights. All Rights Reserved
For sales queries or new topics emailus on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
1/--pages
Report inappropriate content